New hope for PAH patients: experimental drug enters phase 2 trial
NCT ID NCT07318597
First seen Jan 07, 2026 · Last updated May 14, 2026 · Updated 21 times
Summary
This study tests an experimental drug called REGN13335 in 99 adults with pulmonary arterial hypertension (PAH), a condition where high blood pressure in the lungs makes the heart work harder. Participants will receive either the drug or a placebo alongside their usual PAH medications. The goal is to see if REGN13335 can safely lower lung blood vessel resistance and improve heart function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION (PAH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Imperial College Healthcare NHS Trust, Hammersmith Hospital
RECRUITINGLondon, W12 0HS, United Kingdom
-
Seoul National University Hospital
RECRUITINGSeoul, 03080, South Korea
-
University of Colorado Denver
RECRUITINGAurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.